UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Advances in immunotherapy for cervical cancer

Current opinion in oncology, 2020-09, Vol.32 (5), p.481

2020

Volltextzugriff (PDF)

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2825-2834

2019

Volltextzugriff (PDF)

The SHAPE trial: is good is good enough?

Journal of Gynecologic Oncology, 2024, 35(4), , pp.1-4

Naumann, R Wendel

2024

Volltextzugriff (PDF)

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1121-1127

2015

Volltextzugriff (PDF)

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

American journal of obstetrics and gynecology, 2021-10, Vol.225 (4), p.397.e1-397.e6

2021

Volltextzugriff (PDF)

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2013-12, Vol.31 (35), p.4400-4406

2013

Volltextzugriff (PDF)

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

The lancet oncology, 2024-05, Vol.25 (5), p.588-602

2024

Volltextzugriff (PDF)

Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial

Gynecologic oncology, 2024-06, Vol.185, p.143-147

2024

Volltextzugriff (PDF)

TP021/#1540 Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A255-A255

2023

Volltextzugriff (PDF)

Ovarian cancer: screening and future directions

International journal of gynecological cancer, 2019-01, Vol.29 (1), p.195-200

2019

Volltextzugriff (PDF)

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Journal of clinical oncology, 2007-07, Vol.25 (19), p.2811-2818

2007

Volltextzugriff (PDF)

Molecular variations in uterine carcinosarcomas identify therapeutic opportunities

International journal of gynecological cancer, 2020-04, Vol.30 (4), p.480-484

2020

Volltextzugriff (PDF)

Physician pain and discomfort during minimally invasive gynecologic cancer surgery

Gynecologic oncology, 2014-08, Vol.134 (2), p.243-247

2014

Volltextzugriff (PDF)

A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling

International journal of gynecological cancer, 2018-06, Vol.28 (5), p.996-1002

2018

Volltextzugriff (PDF)

The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals

American journal of obstetrics and gynecology, 2012-09, Vol.207 (3), p.174.e1-174.e7

2012

Volltextzugriff (PDF)

Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs

International journal of gynecological cancer, 2015-07, Vol.25 (6), p.1115-1120

2015

Volltextzugriff (PDF)

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Gynecologic oncology, 2017-01, Vol.144 (1), p.200-207

2017

Volltextzugriff (PDF)

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

Journal of minimally invasive gynecology, 2019-03, Vol.26 (3), p.379-380

Naumann, R. Wendel

2019

Volltextzugriff (PDF)

Complications of Electromechanical Morcellation Reported in the Manufacturer and User Facility Device Experience (MAUDE) Database

Journal of minimally invasive gynecology, 2015-09, Vol.22 (6), p.1018-1021

2015

Volltextzugriff (PDF)

Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia

International journal of gynecological cancer, 2018-10, Vol.28 (8), p.1453-1460

2018

Volltextzugriff (PDF)

Physician Education on Controllable Costs Significantly Reduces Cost of Laparoscopic Hysterectomy

Journal of minimally invasive gynecology, 2017-01, Vol.24 (1), p.62-66

2017

Volltextzugriff (PDF)

Re-evaluating “Success” as It Pertains to Surgical Trials

Journal of minimally invasive gynecology, 2021-03, Vol.28 (3), p.496-501

Naumann, R. Wendel

2021

Volltextzugriff (PDF)

Adverse Event Profile by Folate Receptor Status for Vintafolide and Pegylated Liposomal Doxorubicin in Combination, Versus Pegylated Liposomal Doxorubicin Alone, in Platinum-Resistant Ovarian Cancer: Exploratory Analysis of the Phase II PRECEDENT Trial

International journal of gynecological cancer, 2016-11, Vol.26 (9), p.1580-1585

2016

Volltextzugriff (PDF)

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Gynecologic oncology, 2012-07, Vol.126 (1), p.5-11

Naumann, R. Wendel

2012

Volltextzugriff (PDF)

Letter to the Editor: Re: Raspagliesi F, Maltese G, Bogani G, et al. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study. Gynecol Oncol. 2017; 144: 90-5

Gynecologic oncology reports, 2018-02, Vol.23 (C), p.39-40

2018

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Humans
(59)
Female
(58)
Obstetrics & Gynecology
(55)
Oncology
(50)
Middle Aged
(25)
Adult
(22)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Aged
(17)
Ovarian Cancer
(16)
Obstetrics And Gynecology
(14)
Laparoscopy
(12)
Ovarian Neoplasms - Drug Therapy
(12)
Tumors
(12)
Gynecology. Andrology. Obstetrics
(11)
Retrospective Studies
(11)
Surgery
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Advances in immunotherapy for cervical cancer

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial

The SHAPE trial: is good is good enough?

Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology

The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage

PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer

Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1–2, open-label, multicohort trial

Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial

TP021/#1540 Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha

Ovarian cancer: screening and future directions

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

Molecular variations in uterine carcinosarcomas identify therapeutic opportunities

Physician pain and discomfort during minimally invasive gynecologic cancer surgery

A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling

The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals

Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage

Minimally Invasive Radical Hysterectomy Has Many Benefits Compared with Open Radical Hysterectomy: Will the LACC Trial Cause the Premature Demise of This Procedure?

Complications of Electromechanical Morcellation Reported in the Manufacturer and User Facility Device Experience (MAUDE) Database

Complete Resection Is Essential in the Surgical Treatment of Gestational Trophoblastic Neoplasia

Physician Education on Controllable Costs Significantly Reduces Cost of Laparoscopic Hysterectomy

Re-evaluating “Success” as It Pertains to Surgical Trials

Adverse Event Profile by Folate Receptor Status for Vintafolide and Pegylated Liposomal Doxorubicin in Combination, Versus Pegylated Liposomal Doxorubicin Alone, in Platinum-Resistant Ovarian Cancer: Exploratory Analysis of the Phase II PRECEDENT Trial

The role of lymphadenectomy in endometrial cancer: Was the ASTEC trial doomed by design and are we destined to repeat that mistake?

Letter to the Editor: Re: Raspagliesi F, Maltese G, Bogani G, et al. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study. Gynecol Oncol. 2017; 144: 90-5

Suchergebnisse filtern